Pages that link to "Q37495481"
Jump to navigation
Jump to search
The following pages link to Exploiting Temporal Collateral Sensitivity in Tumor Clonal Evolution (Q37495481):
Displaying 38 items.
- An engineering design approach to systems biology (Q30252189) (← links)
- NF-κB signalling and cell fate decisions in response to a short pulse of tumour necrosis factor. (Q30832764) (← links)
- Modeling Tumor Clonal Evolution for Drug Combinations Design (Q33590430) (← links)
- Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer (Q33682922) (← links)
- Differential selective pressure alters rate of drug resistance acquisition in heterogeneous tumor populations (Q37397222) (← links)
- Novel computational method for predicting polytherapy switching strategies to overcome tumor heterogeneity and evolution. (Q37695228) (← links)
- Looking beyond the cancer cell for effective drug combinations (Q38728970) (← links)
- Cellular determinants and microenvironmental regulation of prostate cancer metastasis (Q38730590) (← links)
- From tumour heterogeneity to advances in precision treatment of colorectal cancer (Q38786707) (← links)
- Exploiting receptor tyrosine kinase co-activation for cancer therapy (Q38906990) (← links)
- Tumor Microenvironment and Differential Responses to Therapy (Q39141484) (← links)
- A population genetics perspective on the determinants of intra-tumor heterogeneity (Q39169154) (← links)
- Exploiting Synthetic Lethality and Network Biology to Overcome EGFR Inhibitor Resistance in Lung Cancer. (Q39288360) (← links)
- Time-Resolved Tracking of Mutations Reveals Diverse Allele Dynamics during Escherichia coli Antimicrobial Adaptive Evolution to Single Drugs and Drug Pairs. (Q42248684) (← links)
- Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections. (Q47200948) (← links)
- Spatial competition constrains resistance to targeted cancer therapy. (Q47267135) (← links)
- Modeling the Subclonal Evolution of Cancer Cell Populations (Q49541273) (← links)
- From Chemotherapy to Combined Targeted Therapeutics: In Vitro and in Vivo Models to Decipher Intra-tumor Heterogeneity (Q50351390) (← links)
- The perfect personalized cancer therapy: cancer vaccines against neoantigens. (Q55001351) (← links)
- Taking advantage of drug resistance, a new approach in the war on cancer (Q57172217) (← links)
- Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response (Q58198401) (← links)
- Drug Target Commons 2.0: a community platform for systematic analysis of drug-target interaction profiles (Q58743052) (← links)
- Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance (Q58802587) (← links)
- Antibiotic collateral sensitivity is contingent on the repeatability of evolution (Q60907414) (← links)
- Modeling differentiation-state transitions linked to therapeutic escape in triple-negative breast cancer (Q64109139) (← links)
- A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity (Q83226114) (← links)
- Evolutionary stability of collateral sensitivity to antibiotics in the model pathogen (Q83226401) (← links)
- Treatment resistance in urothelial carcinoma: an evolutionary perspective (Q88548676) (← links)
- New insights from the widening homogeneity perspective to target intratumor heterogeneity (Q88682253) (← links)
- Harnessing Tumor Evolution to Circumvent Resistance (Q89106697) (← links)
- The Promising Connection Between Data Science and Evolutionary Theory in Oncology (Q89622496) (← links)
- Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms (Q89824200) (← links)
- Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer (Q90591550) (← links)
- Limited Evolutionary Conservation of the Phenotypic Effects of Antibiotic Resistance Mutations (Q91784789) (← links)
- mSphere of Influence: Evolutionary Strategies To Sensitize Drug-Resistant Pathogens (Q93051542) (← links)
- Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures (Q94686776) (← links)
- Chemical strategies to overcome resistance against targeted anticancer therapeutics (Q97643334) (← links)
- Characterizing the ecological and evolutionary dynamics of cancer (Q97905754) (← links)